Torbjørn Bjerke
Founder chez Arctic Asset Management AS (Sweden)
Fortune : 679 183 $ au 31/03/2024
Provenance du réseau au premier degré de Torbjørn Bjerke
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
University of Aarhus
49
| College/University | Other Consumer Services | 49 |
| Public Company | Pharmaceuticals: Major | 45 | |
| Public Company | Financial Conglomerates | 21 | |
| Public Company | Trucking | 20 | |
| Unknown | 17 | ||
11
| Public Company | Pharmaceuticals: Major | 11 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna.
10
| Operating Division | Investment Managers | 10 |
| Public Company | Biotechnology | 7 | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Arctic Asset Management AS (Sweden)
 Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients.
3
| Operating Division | Investment Managers | 3 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021.
3
| Private Company | Miscellaneous Commercial Services | 3 |
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The private company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Torbjørn Bjerke via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VESTAS WIND SYSTEMS A/S | Electrical Products | Director of Finance/CFO Chief Executive Officer | |
| DEMANT A/S | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| AURIGA INDUSTRIES A/S | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member | |
Rambøll Gruppen A/S
 Rambøll Gruppen A/S Engineering & ConstructionIndustrial Services Rambøll Gruppen A/S provides engineering, design, and consultancy services. It offers services in the areas of buildings, transportation, water, environment and health, energy, oil and gas, telecom, planning and urban design, and management consulting. The company was founded by Børge Johannes Rambøll and Johan Georg Hannemann on October 15, 1945 and is headquartered in Copenhagen, Denmark. | Engineering & Construction | Corporate Officer/Principal Director/Board Member | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Public Communications Contact Chief Investment Officer Chief Executive Officer Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Imperial College London | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Cheminova A/S
 Cheminova A/S Chemicals: AgriculturalProcess Industries Cheminova A/S manufactures pesticides and other agrochemical products. It offers herbicides, insecticides, fungicides, seed dressings, regulants, grain protectants, and animal health products. The company was founded by Gunnar Andreasen in 1938 and is headquartered in Harboøre, Denma rk. | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| NUNAMINERALS A/S | Precious Metals | Chief Executive Officer Director/Board Member | |
| ORSTED A/S | Electric Utilities | Director/Board Member Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Corporate Officer/Principal Chairman Director/Board Member | |
| KCIF Fund Management AB | Chief Executive Officer Chairman Chief Executive Officer | ||
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| KD Incentive AB | Chairman Director/Board Member | ||
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Director/Board Member Director/Board Member | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chairman | |
| SANA AB | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BETTER COLLECTIVE A/S | Miscellaneous Commercial Services | Director of Finance/CFO Chairman | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Founder | |
Mindway AI ApS
 Mindway AI ApS Information Technology ServicesTechnology Services Mindway AI ApS operates as a software company, which engages in the development of technical solutions for gambling purposes. Its artificial intelligence system works with betting operators, platform providers, regulators, and governments to apply early detection and intervention for safer gambling and gaming activities. The company was founded by Kim Mouridsen and is headquartered in Aarhus, Denmark. | Information Technology Services | Director/Board Member Chief Executive Officer | |
| TXP Pharma GmbH | Chief Executive Officer Founder Corporate Officer/Principal |
Statistiques
Internationale
| Danemark | 20 |
| Suède | 17 |
| France | 5 |
| Etats-Unis | 4 |
| Suisse | 4 |
Sectorielle
| Health Technology | 29 |
| Commercial Services | 6 |
| Consumer Services | 5 |
| Process Industries | 3 |
| Producer Manufacturing | 2 |
Opérationnelle
| Director/Board Member | 620 |
| Corporate Officer/Principal | 216 |
| Chairman | 166 |
| Independent Dir/Board Member | 134 |
| Chief Executive Officer | 83 |
Relations les plus connectées
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Johan Rutger Christenson | 35 |
| Peter Sjöstrand | 35 |
| Bo Jesper Hansen | 34 |
| Michael Wilhelm Rosenlew | 32 |
| Michel de Rosen | 28 |
| Jeppe Øvlesen | 27 |
| Chahra Khaoua Epouse Louafi | 26 |
| Jørgen Drejer | 26 |
| Michael Owens | 25 |
| Michael Shalmi | 25 |
| Flemming Heise Pedersen | 24 |
| Lise Kingo | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Gunilla Anders Ekström | 22 |
- Bourse
- Insiders
- Torbjørn Bjerke
- Connexions Sociétés
